文献速递腹部技术与安全CT

死后CT人工智能体成分生物标志物用于丰富尸检:大型死者队列分析

AI-enabled body composition biomarkers at post-mortem CT for enriching autopsy: analysis of a large decedent cohort.
PubMed 文献 · Abdom Radiol (NY) · 2025-03-18

回顾性分析2010至2017年新墨西哥死者影像数据库6638例无对比剂死后CT,用全自动AI流程量化骨骼肌、皮下/内脏脂肪及主动脉钙化,并与死亡原因和合并症关联;结果显示L3肌肉密度与面积、主动脉Agatston评分、内脏脂肪面积及生物学年龄偏差与急性/慢性死亡及慢性病相关。

要点

  • L3肌肉密度急性死亡组26 HU高于慢性死亡组18 HU,肌肉面积192 cm²高于183 cm²。
  • 心脏病死者主动脉Agatston评分5120高于非心脏病死者2098。
  • 糖尿病患者L3内脏脂肪面积227 cm²高于非糖尿病175 cm²,肌肉密度17 HU低于25 HU。

核心结论

  • 全自动定量死后CT组织生物标志物与死亡的时间性质及慢性合并症相关,支持其用于丰富尸检。

研究设计与样本

  • 回顾性研究,纳入新墨西哥死者影像数据库2010至2017年无对比剂死后CT扫描6638例死者,平均年龄50±18岁(标准差),74%为男性。

关键影像表现/征象

  • L3水平肌肉密度急性死亡组26 HU vs 慢性死亡组18 HU(p<0.001),肌肉面积急性组192 cm² vs 慢性组183 cm²(p<0.001)。
  • 无癌症者L3肌肉密度25 HU vs 癌症者16 HU(p<0.001),肌肉面积无癌症者190 cm² vs 癌症者169 cm²(p<0.01)。
  • 心脏病死者主动脉Agatston评分5120 vs 非心脏病死者2098(p<0.001)。
  • 糖尿病患者L3内脏脂肪面积227 cm² vs 非糖尿病175 cm²(p<0.001),肌肉密度糖尿病17 HU vs 非糖尿病25 HU(p<0.001)。

诊断标准与关键数值

  • 死亡原因分类为「急性」「慢性」或「不确定」:急性占80%,慢性占10%,不确定占10%。
  • 排除标准为扫描存在超过轻微程度的腐败分解。
  • 采用预设模型从CT推导「生物学年龄」,慢性死亡组与实足年龄偏差中位数19年 vs 急性组10年(p<0.001)。

临床应用与阅片要点

  • AI驱动的自动化流程可从死后CT腹部组分量化骨骼肌、皮下/内脏脂肪及主动脉钙化。
  • L3肌肉密度与面积较低、主动脉Agatston评分较高、内脏脂肪面积较高及肌肉密度较低分别与慢性死亡、心脏病死亡及糖尿病相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To correlate fully-automated PMCT-based body composition measures with causes of death and comorbidities.

MATERIALS AND METHODS: Retrospective study of New Mexico Decedent Image Database (NMDID) with non-contrast PMCT scans between 2010 and 2017. Automated pipeline of AI-driven algorithms for quantifying skeletal muscle, subcutaneous/visceral fat, and aortic calcification from the abdominal component of PMCT scans was used. Scans with more than minimal decomposition were excluded. Cause of death was categorized as "acute" or "chronic." A predetermined model derived CT-based "biological age."

RESULTS: 6638 decedents (mean age, 50±18 [SD]; 74% male) comprised the final cohort. 80% of deaths were classified as "acute," 10% as "chronic," and 10% "uncertain." Muscle density (HU) and area at the L3 lumbar level were higher in the "acute" versus "chronic" group (26 HU vs. 18 HU, p < 0.001; 192 cm2 vs. 183 cm2, p < 0.001). Muscle density and area at the L3 level were higher among those without cancer (25 HU vs. 16 HU, p < 0.001; 190 cm2 vs. 169 cm2, p < 0.01). Aortic Agatston scores were higher in those who died of heart disease (5120 vs. 2098, p < 0.001). Diabetic patients had higher L3 visceral fat area (227 cm2 vs. 175 cm2, p < 0.001) and lower muscle density (17 HU vs. 25 HU, p < 0.001). The deviation between chronological and biological age was significantly higher in the chronic versus acute group (median age deviation, 19 years vs. 10 years; p < 0.001).

CONCLUSION: Fully-automated quantitative PMCT-based tissue biomarkers correlate with the temporal nature of death and chronic co-morbidities, supporting their use for enhancing autopsies.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Golden MV, Lee MH, Garrett JW, et al. AI-enabled body composition biomarkers at post-mortem CT for enriching autopsy: analysis of a large decedent cohort. Abdom Radiol (NY). 2025. PMID: 40100280. doi:10.1007/s00261-025-04878-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。